DataDrivenInvestor December 6, 2023
Flavio Aliberti

Explore Big Pharma’s M&A trends, their impact on supply chains, and the urgent need for adaptability in a rapidly evolving healthcare landscape However, researching partnerships, acquisitions, and divestments made by large multinational firms over time reveals trends and evolutionary patterns in the ecosystem. In this article, I will consider some mergers and acquisitions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose

Share This Article